Connect with us

Coronavirus Vaccine

Prime Minister Reviews Vaccine Development, Manufacturing At Three Facilities

The visit, PM Modi’s office said, was meant to help him get a “first-hand perspective of the preparations, challenges and roadmap in India’s endeavour to vaccinate its citizens against COVID-19

Prime Minister Reviews Vaccine Development, Manufacturing At Three Facilities
  • PM Modi visited vaccine manufacturers in Ahmedabad, Hyderabad and Pune
  • PM spoke on the efforts being made by India towards vaccine development
  • PM Modi stressed that India considers vaccines as a global good

Ahmedabad/Hyderabad/Pune: Prime Minister Narendra Modi on Saturday (November 28) visited Ahmedabad, Hyderabad and Pune to review the development and manufacturing process of coronavirus vaccines at facilities in these cities. He visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune. “The scientists expressed joy that the Prime Minister met them face to face in order to boost their morale and help accelerate their efforts at this critical juncture in the vaccine development journey. The Prime Minister expressed pride in the fact that India’s indigenous vaccine development has progressed at such a rapid pace so far. He spoke on how India is following sound principles of science in the entire journey of vaccine development, while also asking for suggestions to make the vaccine distribution process better,” an official statement said.

Also Read: High Storage Cost Of Ultra-Cold COVID-19 Vaccines Should Not Hinder Use: World Health Organisation

The statement said PM Modi stressed that India considers vaccines as not only vital to good health but also as a global good, and it is India’s duty to assist other countries, including the nations in our neighbourhood, in the collective fight against the virus.

He (PM Modi) asked the scientists to express their free and frank opinion on how the country could further improve its regulatory process. The scientists also presented an over view of how they are also developing various new and repurposed drugs to better fight COVID-19, it said.

Mr. Modi began by visiting pharma major Zydus Cadila’s manufacturing facility near Ahmedabad. Wearing a PPE (Personal Protective Equipment) kit, he reviewed the vaccine development process at the company’s research centre, located over 20 km from Ahmedabad.

Mr. Modi was extensively briefed about the vaccine work at the plant by the company officials. He was briefed about the vaccine production procedure. He interacted with scientists and vaccine developers, an official said.

Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey, Mr. Modi tweeted after the visit.

Zydus Cadila chairman Pankaj Patel recently said the company is aiming to complete the vaccine trial by March 2021, and could produce up to 100 million doses a year. PM Modi, who landed at Ahmedabad at 9.10 am, spent over an hour at the plant, before leaving for the airport, from where he left for Hyderabad at 11.40 am.

Also Read: Government Keeping A Close Eye On COVID-19 Vaccine Development: Prime Minister Narendra Modi

PM Modi landed at Hakimpet Air Force station near Hyderabad around 1 pm and proceeded to pharma major Bharat Biotech’s vaccine manufacturing facility at Genome valley, located around 20 km from the air station, by road.

At the facility, he reviewed the progress of Covaxin, a vaccine candidate being developed by the company. He also interacted with Bharat Biotech Chairman and Managing Director Krishna Ella, scientists and senior management.

At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress, PM Modi tweeted after his hour-long visit there.

After leaving the facility, PM Modi got down from his vehicle at the main gate and waved to media persons and the cheering crowd standing nearby. Covaxin, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, is undergoing phase-3 trials. At 3.20 pm, PM Modi took off for Pune, where he landed at4.30 pm on the last leg of his three-city vaccine work review visit.

Also Read: Centre May Purchase 300-400 Million Covishield Doses By July 2021: Serum Institute’s Adar Poonawalla

PM Modi then proceeded by helicopter to the campus of the Serum Institute of India (SII) at Manjari, located 17 km from the airport. At the Serum Institute of India, Modi reviewed the progress of the ‘Covishield’ vaccine being made there.

PM Modi interacted with scientists at the Serum Institute and had a walkabout of the facility, taking stock of vaccine development work being carried out there. At the facility, Modi was received by Dr Cyrus Poonawalla, chairman of Poonwalla Group, and his son and SII CEO Adar Poonawalla. They briefed PM Modi about the work being carried out at SII.

PM Modi interacted with the Poonawallas, scientists and other executives, who briefed him on the vaccine’s progress.

Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility, PM Modi tweeted after his SII visit.

Serum Institute of India has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine. Modi left from SII for Pune airport around 6 pm and took off for Delhi at 6.25 pm, an official said.

Also Read: Centre Asks States, Union Territories To Form Block Level Task Force For COVID-19 Vaccine Rollout

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene


Coronavirus has spread to 196 countries. The total confirmed cases worldwide are 26,21,50,955 and 52,07,350 have died; 22,29,25,306 are active cases and 3,40,18,299 have recovered as on November 30, 2021 at 3:50 am.


3,45,87,822 6,990Cases
3,40,18,299 10,116Recovered
4,68,980 190Deaths
In India, there are 3,45,87,822 confirmed cases including 4,68,980 deaths. The number of active cases is 1,00,543 and 3,40,18,299 have recovered as on November 30, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths

66,34,980 536

11,525 338

64,82,493 853

1,40,962 21


51,37,091 3,382

45,138 2,514

50,51,998 5,779

39,955 117


29,95,857 257

6,907 47

29,50,747 205

38,203 5

Tamil Nadu

27,26,197 730

8,291 46

26,81,434 767

36,472 9

Andhra Pradesh

20,72,725 101

2,102 38

20,56,184 138

14,439 1

Uttar Pradesh

17,10,387 5

86 3

16,87,391 2


West Bengal

16,15,378 511

7,733 71

15,88,172 571

19,473 11


14,40,900 34

285 3

14,15,517 36

25,098 1


10,48,880 197

2,165 26

10,38,306 221

8,409 2


10,06,779 16

318 12

9,92,868 28



9,54,770 12

187 12

9,45,628 24



8,27,435 27

262 22

8,17,081 49


Madhya Pradesh

7,93,150 12

126 4

7,82,496 8



7,71,692 16

165 3

7,61,473 19



7,26,219 2

39 2

7,16,517 4



6,75,798 184

3,581 46

6,68,227 137

3,990 1


6,16,708 140

2,595 96

6,08,015 230

6,098 6


6,03,258 18

329 11

5,86,330 26

16,599 3


3,49,232 11

95 2

3,43,997 9



3,44,227 8

132 44

3,36,687 51

7,408 1

Jammu And Kashmir

3,36,681 150

1,626 32

3,30,579 181

4,476 1

Himachal Pradesh

2,27,093 90

824 29

2,22,422 61



1,78,890 24

276 3

1,75,230 19

3,384 2


1,34,810 437

3,805 95

1,30,512 531

493 1


1,28,893 12

296 16

1,26,725 28



1,25,169 17

655 30

1,22,539 43

1,975 4


84,791 4

78 8

83,890 10

823 2


84,461 17

285 16

82,704 32

1,472 1


65,456 8

58 4

64,578 4


Arunachal Pradesh

55,273 4

35 2

54,958 2



32,233 5

121 6

31,709 11



32,109 9

140 5

31,273 4



21,540 12

250 18

21,076 29

214 1

Dadra And Nagar Haveli


1 0





24 4

10,319 4


Andaman And Nicobar Islands

7,683 2

8 2



Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Highlights From The 12-Hour Telethon

Leaving No One Behind

Mental Health


Join Us